154 related articles for article (PubMed ID: 23230282)
1. What dictates the accumulation of desmosterol in the developing brain?
Jansen M; Wang W; Greco D; Bellenchi GC; di Porzio U; Brown AJ; Ikonen E
FASEB J; 2013 Mar; 27(3):865-70. PubMed ID: 23230282
[TBL] [Abstract][Full Text] [Related]
2. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
[TBL] [Abstract][Full Text] [Related]
3. How essential is cholesterol?
Stevenson J; Brown AJ
Biochem J; 2009 May; 420(2):e1-4. PubMed ID: 19426142
[TBL] [Abstract][Full Text] [Related]
4. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line.
Rodríguez-Acebes S; de la Cueva P; Fernández-Hernando C; Ferruelo AJ; Lasunción MA; Rawson RB; Martínez-Botas J; Gómez-Coronado D
Biochem J; 2009 May; 420(2):305-15. PubMed ID: 19260826
[TBL] [Abstract][Full Text] [Related]
5. Desmosterolosis and desmosterol homeostasis in the developing mouse brain.
Allen LB; Genaro-Mattos TC; Porter NA; Mirnics K; Korade Z
J Inherit Metab Dis; 2019 Sep; 42(5):934-943. PubMed ID: 30891795
[TBL] [Abstract][Full Text] [Related]
6. Dehydrocholesterol Reductase 24 (DHCR24): Medicinal Chemistry, Pharmacology and Novel Therapeutic Options.
Müller C; Hank E; Giera M; Bracher F
Curr Med Chem; 2022; 29(23):4005-4025. PubMed ID: 34781860
[TBL] [Abstract][Full Text] [Related]
7. Desmosterol in brain is elevated because DHCR24 needs REST for Robust Expression but REST is poorly expressed.
Tint GS; Pan L; Shang Q; Sharpe LJ; Brown AJ; Li M; Yu H
Dev Neurosci; 2014; 36(2):132-42. PubMed ID: 24861183
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- mice.
Kuehnle K; Ledesma MD; Kalvodova L; Smith AE; Crameri A; Skaanes-Brunner F; Thelen KM; Kulic L; Lütjohann D; Heppner FL; Nitsch RM; Mohajeri MH
Neurochem Res; 2009 Jun; 34(6):1167-82. PubMed ID: 19115107
[TBL] [Abstract][Full Text] [Related]
9. The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1).
Zerenturk EJ; Kristiana I; Gill S; Brown AJ
Biochim Biophys Acta; 2012 Sep; 1821(9):1269-77. PubMed ID: 22178193
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.
Waterham HR; Koster J; Romeijn GJ; Hennekam RC; Vreken P; Andersson HC; FitzPatrick DR; Kelley RI; Wanders RJ
Am J Hum Genet; 2001 Oct; 69(4):685-94. PubMed ID: 11519011
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: neuroprogesterone, epoxycholesterol, and ABC transporters as determinants of neurodesmosterol tissue levels and its role in amyloid protein processing.
Javitt NB
J Alzheimers Dis; 2013; 35(3):441-50. PubMed ID: 23455994
[TBL] [Abstract][Full Text] [Related]
12. Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.
Zhang X; McDonald JG; Aryal B; Canfrán-Duque A; Goldberg EL; Araldi E; Ding W; Fan Y; Thompson BM; Singh AK; Li Q; Tellides G; Ordovás-Montanes J; García Milian R; Dixit VD; Ikonen E; Suárez Y; Fernández-Hernando C
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782454
[TBL] [Abstract][Full Text] [Related]
13. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay.
Andersson HC; Kratz L; Kelley R
Am J Med Genet; 2002 Dec; 113(4):315-9. PubMed ID: 12457401
[TBL] [Abstract][Full Text] [Related]
14. Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.
Pfeifer T; Buchebner M; Chandak PG; Patankar J; Kratzer A; Obrowsky S; Rechberger GN; Kadam RS; Kompella UB; Kostner GM; Kratky D; Levak-Frank S
Curr Pharm Biotechnol; 2011 Feb; 12(2):285-92. PubMed ID: 21190543
[TBL] [Abstract][Full Text] [Related]
15. Alterations in brain cholesterol metabolism in the APPSLxPS1mut mouse, a model for Alzheimer's disease.
Vanmierlo T; Bloks VW; van Vark-van der Zee LC; Rutten K; Kerksiek A; Friedrichs S; Sijbrands E; Steinbusch HW; Kuipers F; Lütjohann D; Mulder M
J Alzheimers Dis; 2010; 19(1):117-27. PubMed ID: 20061631
[TBL] [Abstract][Full Text] [Related]
16. DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis.
Mirza R; Hayasaka S; Takagishi Y; Kambe F; Ohmori S; Maki K; Yamamoto M; Murakami K; Kaji T; Zadworny D; Murata Y; Seo H
J Invest Dermatol; 2006 Mar; 126(3):638-47. PubMed ID: 16410790
[TBL] [Abstract][Full Text] [Related]
17. E2012-induced cataract and its predictive biomarkers.
Nakano-Ito K; Fujikawa Y; Hihara T; Shinjo H; Kotani S; Suganuma A; Aoki T; Tsukidate K
Toxicol Sci; 2014 Jan; 137(1):249-58. PubMed ID: 24085193
[TBL] [Abstract][Full Text] [Related]
18. Homology modelling of human DHCR24 (seladin-1) and analysis of its binding properties through molecular docking and dynamics simulations.
Pedretti A; Bocci E; Maggi R; Vistoli G
Steroids; 2008 Aug; 73(7):708-19. PubMed ID: 18394665
[TBL] [Abstract][Full Text] [Related]
19. The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene.
Wang Y; Rogers PM; Stayrook KR; Su C; Varga G; Shen Q; Nagpal S; Burris TP
Mol Pharmacol; 2008 Dec; 74(6):1716-21. PubMed ID: 18815215
[TBL] [Abstract][Full Text] [Related]
20. New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm.
Peri A; Danza G; Benvenuti S; Luciani P; Deledda C; Rosati F; Cellai I; Serio M
Front Neuroendocrinol; 2009 Jul; 30(2):119-29. PubMed ID: 19351544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]